Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Multiple Myeloma 5Neoplasms 3Glioma 2Unspecified Childhood Solid Tumor, Protocol Specific 1Rhabdoid Tumor 1Ovarian Neoplasms 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive 1Medulloblastoma 1Glioblastoma 1Fallopian Tube Neoplasms 1Diffuse Intrinsic Pontine Glioma 1Breast Neoplasms 1Brain Neoplasms 1Astrocytoma 1Anemia 1

Interventions

Radiotherapy 6Radiation 3Panobinostat 3Cyclophosphamide 3ribociclib 2Temozolomide 2Specimen Handling 2Magnetic Resonance Spectroscopy 2Everolimus 2Etoposide 2Dasatinib 2vandetanib 1temsirolimus 1spartalizumab 1sargramostim 1reolysin 1pembrolizumab 1ovex 1marizomib 1irinotecan sucrosofate 1gallium maltolate 1etoposide phosphate 1crenolanib 1balstilimab 1adavosertib 1abemaciclib 1X-Rays 1Vorinostat 1Vaccines 1Topotecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Diffuse Intrinsic Pontine Glioma × reolysin × Clear all
NCT02444546 2023-04-24

Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors

Mayo Clinic

Phase 1 Completed
6 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Brain Neoplasms, Glioma, Medulloblastoma, Oligodendroglioma, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡